US20070112436A1 - Sintered body of titanium compound - Google Patents

Sintered body of titanium compound Download PDF

Info

Publication number
US20070112436A1
US20070112436A1 US10/581,741 US58174104A US2007112436A1 US 20070112436 A1 US20070112436 A1 US 20070112436A1 US 58174104 A US58174104 A US 58174104A US 2007112436 A1 US2007112436 A1 US 2007112436A1
Authority
US
United States
Prior art keywords
sintered body
titanium compound
sintering
titanium
production method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/581,741
Other languages
English (en)
Inventor
Tatsushi Fujita
Kenichi Tamura
Yuriko Morisaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IMMUNO-SCIENCE Co Inc
Immuno Science Co Ltd
Original Assignee
Immuno Science Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Science Co Ltd filed Critical Immuno Science Co Ltd
Assigned to IMMUNO-SCIENCE CO., INC. reassignment IMMUNO-SCIENCE CO., INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MORISAKI, YURIKO, FUJITA, TATSUSHI, TAMURA, KENICHI
Publication of US20070112436A1 publication Critical patent/US20070112436A1/en
Priority to US12/240,482 priority Critical patent/US7803194B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B25/00—Phosphorus; Compounds thereof
    • C01B25/16—Oxyacids of phosphorus; Salts thereof
    • C01B25/26—Phosphates
    • C01B25/32—Phosphates of magnesium, calcium, strontium, or barium
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/01—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on oxide ceramics
    • C04B35/447—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on oxide ceramics based on phosphates, e.g. hydroxyapatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G23/00—Compounds of titanium
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/30—Constituents and secondary phases not being of a fibrous nature
    • C04B2235/32—Metal oxides, mixed metal oxides, or oxide-forming salts thereof, e.g. carbonates, nitrates, (oxy)hydroxides, chlorides
    • C04B2235/3205—Alkaline earth oxides or oxide forming salts thereof, e.g. beryllium oxide
    • C04B2235/3208—Calcium oxide or oxide-forming salts thereof, e.g. lime
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/30—Constituents and secondary phases not being of a fibrous nature
    • C04B2235/32—Metal oxides, mixed metal oxides, or oxide-forming salts thereof, e.g. carbonates, nitrates, (oxy)hydroxides, chlorides
    • C04B2235/3205—Alkaline earth oxides or oxide forming salts thereof, e.g. beryllium oxide
    • C04B2235/3208—Calcium oxide or oxide-forming salts thereof, e.g. lime
    • C04B2235/3212—Calcium phosphates, e.g. hydroxyapatite
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/30—Constituents and secondary phases not being of a fibrous nature
    • C04B2235/32—Metal oxides, mixed metal oxides, or oxide-forming salts thereof, e.g. carbonates, nitrates, (oxy)hydroxides, chlorides
    • C04B2235/3231—Refractory metal oxides, their mixed metal oxides, or oxide-forming salts thereof
    • C04B2235/3232—Titanium oxides or titanates, e.g. rutile or anatase
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/30—Constituents and secondary phases not being of a fibrous nature
    • C04B2235/32—Metal oxides, mixed metal oxides, or oxide-forming salts thereof, e.g. carbonates, nitrates, (oxy)hydroxides, chlorides
    • C04B2235/3231—Refractory metal oxides, their mixed metal oxides, or oxide-forming salts thereof
    • C04B2235/3232—Titanium oxides or titanates, e.g. rutile or anatase
    • C04B2235/3234—Titanates, not containing zirconia
    • C04B2235/3236—Alkaline earth titanates
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/30—Constituents and secondary phases not being of a fibrous nature
    • C04B2235/44—Metal salt constituents or additives chosen for the nature of the anions, e.g. hydrides or acetylacetonate
    • C04B2235/447—Phosphates or phosphites, e.g. orthophosphate, hypophosphite
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/65—Aspects relating to heat treatments of ceramic bodies such as green ceramics or pre-sintered ceramics, e.g. burning, sintering or melting processes
    • C04B2235/656—Aspects relating to heat treatments of ceramic bodies such as green ceramics or pre-sintered ceramics, e.g. burning, sintering or melting processes characterised by specific heating conditions during heat treatment
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/65—Aspects relating to heat treatments of ceramic bodies such as green ceramics or pre-sintered ceramics, e.g. burning, sintering or melting processes
    • C04B2235/658—Atmosphere during thermal treatment
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/65—Aspects relating to heat treatments of ceramic bodies such as green ceramics or pre-sintered ceramics, e.g. burning, sintering or melting processes
    • C04B2235/658—Atmosphere during thermal treatment
    • C04B2235/6581—Total pressure below 1 atmosphere, e.g. vacuum
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/70—Aspects relating to sintered or melt-casted ceramic products
    • C04B2235/74—Physical characteristics
    • C04B2235/76—Crystal structural characteristics, e.g. symmetry
    • C04B2235/768—Perovskite structure ABO3
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/70—Aspects relating to sintered or melt-casted ceramic products
    • C04B2235/80—Phases present in the sintered or melt-cast ceramic products other than the main phase
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/70—Aspects relating to sintered or melt-casted ceramic products
    • C04B2235/96—Properties of ceramic products, e.g. mechanical properties such as strength, toughness, wear resistance

Definitions

  • the present invention relates to a novel titanium compound. Further, the present invention relates to a sintered body of a titanium compound obtained by sintering the titanium compound, and a method for producing the same. Further, the present invention relates to an artificial bone material, an artificial joint material, an artificial tooth material or an artificial dental root (implant) material, constituted of those sintered bodies of the titanium compound. Further, the present invention relates to an artificial bone, an artificial joint, an artificial tooth or an artificial dental root, comprising those sintered bodies of the titanium compound.
  • Apatite has excellent bioaffinity and can directly be bonded to a bone tissue. Therefore, the apatite is widely used as a material for an artificial bone or an artificial dental root. Above all, calcium hydroxyapatite is a main component of a living hard tissue such as a bone or a tooth, and therefore is one of materials most well utilized. Further, it is known that ⁇ -tricalcium phosphate (hereinafter referred to as “ ⁇ -TCP”) is easily absorbed in a bone, and is easily substituted with a new bone after being embedded in a living body.
  • ⁇ -TCP ⁇ -tricalcium phosphate
  • titanium has excellent strength and has low reactivity to a living body, and for this reason, is widely used as a material for an artificial joint or an artificial dental root (JP-A-63-143057).
  • the material for an artificial joint, an artificial dental root, and the like is strongly bonded to a bone tissue, and is united with the bone tissue.
  • titanium has low reactivity to a living body as described above, but on the other hand, has low affinity with a living tissue. Therefore, it was difficult to unite titanium with a bone tissue.
  • inorganic substances there are some substances to be difficult to sinter the same alone as in ⁇ -TCP or the like. It is not known that the inorganic substance is mixed with the titanium compound above, and then sintered.
  • the objects of the present invention are to provide a sintered body of a titanium compound obtained by sintering the titanium compound, and a method for producing the same. Further, the objects of the present invention are to provide a sintered body obtained by sintering a mixture of a titanium compound and an inorganic substance, and a method for producing the same.
  • a sintered body of a titanium compound can be obtained by sintering the titanium compound under specific conditions, and such a sintered body is suitable as a material for an artificial bone and the like, and have completed the present invention. Further, the present inventors have found that a sintered body can be obtained by sintering a mixture containing a titanium compound and an inorganic substance under specific conditions, and such a sintered body is suitable as a material for an artificial bone and the like, and have completed the present invention.
  • the present invention is a titanium compound represented by the following formula (1) or (2): [Ca 10 (P 4 ) 6 ]TiO3.nH 2 O (1) [Ca 10 (PO 4 ) 6 ]TiO 2 (OH) 2 (2) (In the formulae, n is an integer of from 0 to 3).
  • the present invention is a sintered body obtained by sintering a titanium compound.
  • the present invention is the above-described sintered body, wherein the titanium compound is represented by the formula (1) or (2).
  • the present invention is the above-described sintered body, wherein the titanium compound is produced by adding an alkali to a solution containing a calcium ion, a titanium ion and phosphoric ion, thereby coprecipitating.
  • the present invention is a sintered body comprising perovskite and whitlockite.
  • the present invention is a sintered body substantially consisting of perovskite and whitlockite.
  • the present invention is the above-described sintered body, wherein the perovskite and whitlockite are obtained by sintering a titanium compound.
  • the present invention is the above-described sintered body, wherein the titanium compound is represented by the formula (1) or (2).
  • the present invention is the above-described sintered body, wherein the titanium compound is produced by adding an alkali to a solution containing a calcium ion, a titanium ion and phosphoric ion, thereby coprecipitating.
  • the present invention is a method for producing a sintered body, comprising sintering a titanium compound.
  • the present invention is the above-described production method, wherein the titanium compound is represented by the formula (1) or (2).
  • the present invention is the above-described production method, wherein the titanium compound is produced by adding an alkali to a solution containing a calcium ion, a titanium ion and phosphoric ion, thereby coprecipitating.
  • the present invention is the above-described production method, wherein the sintering is conducted at a temperature exceeding 800° C.
  • the present invention is the above-described production method, wherein the sintering is conducted under an inert gas atmosphere and/or under reduced pressure.
  • the present invention is the above-described production method, wherein the inert gas is xenon and/or argon.
  • the present invention is the above-described production method, wherein the sintering is conducted under a pressure of 10 ⁇ 4 Pa or lower.
  • the present invention is a sintered body obtained by sintering a mixture containing a titanium compound and an inorganic substance.
  • the present invention is the above-described sintered body, wherein the titanium compound is represented by the formula (1) or (2).
  • the present invention is the above-described sintered body, wherein the titanium compound is produced by adding an alkali to a solution containing a calcium ion, a titanium ion and phosphoric ion, thereby coprecipitating.
  • the present invention is the above-described sintered body, wherein the inorganic substance is at least one selected from the group consisting of calcium hydroxyapatite, calcium fluoroapatite, ⁇ -tricalcium phosphate, ⁇ -tricalcium phosphate, tetracalcium phosphate, metallic titanium, titanium oxide and platinum.
  • the inorganic substance is at least one selected from the group consisting of calcium hydroxyapatite, calcium fluoroapatite, ⁇ -tricalcium phosphate, ⁇ -tricalcium phosphate, tetracalcium phosphate, metallic titanium, titanium oxide and platinum.
  • the present invention is a method for producing a sintered body, comprising sintering a mixture containing a titanium compound and an inorganic substance.
  • the present invention is the above-described production method, wherein the titanium compound is represented by the formula (1) or (2).
  • the present invention is the above-described production method, wherein the titanium compound is produced by adding an alkali to a solution containing a calcium ion, a titanium ion and phosphoric ion, thereby coprecipitating.
  • the present invention is the above-described production method, wherein the inorganic substance is at least one selected from the group consisting of calcium hydroxyapatite, calcium fluoroapatite, ⁇ -tricalcium phosphate, ⁇ -tricalcium phosphate, tetracalcium phosphate, metallic titanium, titanium oxide and platinum.
  • the present invention is the above-described production method, wherein the sintering is conducted at a temperature exceeding 800° C.
  • the present invention is the above-described production method, wherein the sintering is conducted under an inert gas atmosphere and/or under reduced pressure.
  • the present invention is the above-described production method, wherein the inert gas is xenon and/or argon.
  • the present invention is the above-described production method, wherein the sintering is conducted under a pressure of 10 ⁇ 4 Pa or lower.
  • the present invention is an artificial bone material, an artificial joint material, an artificial tooth material or an artificial dental root material, constituted of the above-described sintered body.
  • the present invention is an artificial bone, an artificial joint, an artificial tooth or an artificial dental root, comprising the above-described sintered body.
  • the upper column of FIG. 1 is a view showing X ray diffraction result of the sintered body of a titanium compound of the present invention
  • the middle column is a view showing X ray diffraction pattern of whitlockite
  • the lower column is a view showing X ray diffraction pattern of perovskite.
  • FIG. 2 is a view showing the relationship between a sintering temperature of the sintered body of a titanium compound and microvickers hardness.
  • FIG. 3 is a view showing microvickers hardness of the sintered body of a mixture of the titanium compound and ⁇ -TCP.
  • the titanium compound of the present invention is represented by the following formula (1) or (2), and has a structure of titanic acid apatite: [Ca 10 (PO 4 ) 6 ]TiO 3 .nH 2 O (1) [Ca 10 (PO 4 ) 6 ]TiO 2 (OH) 2 (2) (In the formulae, n is an integer of from 0 to 3).
  • n is from 0 to 3, and is preferably 1 or 2.
  • the titanium compound of the present invention can be produced by, for example, a coprecipitation method of adding an alkali to a solution containing a calcium ion, a titanium ion and phosphoric ion, thereby coprecipitating. Specifically, for example, phosphoric acid is added to an aqueous solution containing calcium nitrate, titanium sulfate and a small amount of an alkali component dissolved therein, followed by aqueous ammonia is added to adjust pH to the vicinity of 9, and the suspension obtained is stirred at 80 to 100° C. for 4 to 8 hours, thereby a dispersion of the titanium compound can be obtained.
  • phosphoric acid is added to an aqueous solution containing calcium nitrate, titanium sulfate and a small amount of an alkali component dissolved therein, followed by aqueous ammonia is added to adjust pH to the vicinity of 9, and the suspension obtained is stirred at 80 to 100° C. for 4 to 8 hours, thereby a dis
  • This solution is filtered, and the material filtered off is washed and dried, thereby a powder of the titanium compound of the present invention can be produced.
  • formation of calcium sulfate can be suppressed by adding a small amount of an alkali component.
  • the sintered body of the titanium compound of the present invention can be produced by sintering a powder of the titanium compound at a temperature exceeding 800° C. Where the temperature is 800° C. or lower, there is the possibility that the titanium compound cannot be sintered, or a sintered material easily disintegrates.
  • the upper limit of the sintering temperature is not particularly limited so long as the titanium compound can be sintered, but it is preferable to sinter at 1,500° C. or lower.
  • the sintered body of the titanium compound of the present invention is preferable to sinter the titanium compound under an inert gas atmosphere and/or under reduced pressure.
  • the inert gas used here is preferably xenon and/or argon.
  • pressure when sintering is preferably atmospheric pressure ( 10 5 Pa) or lower, more preferably 10 Pa or lower, further preferably 10 ⁇ 2 Pa or lower, and most preferably 10 ⁇ 4 Pa or lower.
  • the sintering may be conducted only under an inert gas atmosphere, or only under reduced pressure. However, it is more preferable that the sintering is conducted under an inert gas atmosphere and also under reduced pressure.
  • the sintering time is not particularly limited so long as the sintered body of the titanium compound is obtained.
  • the sintering time can be 15 minutes or more, preferably 12 hours or more, more preferably 24 hours or more, and further preferably 48 hours or more. There is the tendency that longer sintering time provides a sintered body having higher hardness.
  • the upper limit of the sintering time is not particularly limited, and can appropriately be determined according the hardness of the sintered body, and the like. However, for example, the upper limit can be 72 hours or less, and preferably 36 hours or less.
  • sintering for 30 minutes under an atmospheric pressure it is preferable to sinter at 1,250 to 1,450° C., and when sintering for 30 minutes at 10 ⁇ 4 Pa, it is preferable to sinter at 850 to 1,350° C.
  • the sintered body of the titanium compound of the present invention comprises perovskite (CaTiO 3 ) and whitlockite (Ca 3 (PO 4 ) 2 ).
  • perovskite CaTiO 3
  • whitlockite Ca 3 (PO 4 ) 2
  • ⁇ -TCP ⁇ -tricalcium phosphate
  • anatase titanium dioxide or hydroxylapatite is not substantially contained in the sintered body of the titanium compound.
  • the inorganic substance used in the present invention is not particularly limited so long as a sintered body can be obtained by mixing with the titanium compound.
  • a sintered body can be obtained by mixing with the titanium compound.
  • calcium hydroxyapatite, calcium fluoroapatite, ⁇ -TCP, ⁇ -TCP, tetracalcium phosphate, metallic titanium, titanium oxide, platinum, and the like can be mentioned.
  • ⁇ -TCP is preferable from the point that it can easily be substituted with a bone tissue in a living tissue.
  • those inorganic substances may be used alone or as mixtures of two or more thereof.
  • the sintered body of the mixture of the titanium compound and the inorganic substance of the present invention can be produced by sintering the mixture of the titanium compound and the inorganic substance at a temperature exceeding 800° C.
  • the mixing ratio of the titanium compound and the inorganic substance is not particularly limited so long as a sintered body of the mixture is obtained.
  • Weight ratio of titanium compound: inorganic substance can be 99:1 to 1:99, preferably 95:5 to 30:70, and more preferably 90:10 to 50:50.
  • Inert gas, pressure, temperature range, time, and the like used when sintering are appropriately determined depending on properties of the inorganic substance or its mixing ratio, but can be nearly the same as the conditions when producing the sintered body of the titanium compound as described above.
  • Example 2 About 3 g of the powder of the titanium compound obtained in Example 1 was kneaded with purified water, and placed in a mold, molded, and then air-dried. The air-dried product was dried in a drying oven at 100° C. for 24 hours. The dried sample was placed in a vacuum heat-treating machine, and held at various temperatures under an atmospheric pressure or in vacuum (10 ⁇ 4 Pa) for 30 minutes to sinter the same. After stopping the heating, the sample was allowed to stand to room temperature. Regarding the sample sintered in vacuum, it was allowed to stand to room temperature, and after introducing argon gas, and was taken out. Regarding the sintered body of the titanium compound obtained, crystal analysis by X ray diffraction was conducted. FIG.
  • FIG. 1 shows the result of X ray diffraction in the case of sintering at 1,300° C. in vacuum. Further, FIG. 1 also shows X ray diffraction patterns of perovskite and whitlockite. Further, the results are summarized in Table 1.
  • FIG. 2 It is seen from FIG. 2 that a sintered body of a titanium compound, having high hardness is obtained. Further, it is seen that a sintered body having higher hardness can be obtained in the case of sintering in vacuum, as compared with the case of sintering under atmospheric pressure.
  • ⁇ -TCP which is difficult to sinter alone, can be sintered by mixing with a titanium compound. Further, it is seen that the obtained sintered body of a mixture of the titanium compound and ⁇ -TCP has hardness equal to or higher than the case of the titanium compound alone.
  • the sintered body of the titanium compound of the present invention has high hardness, and can be used as an artificial bone material, an artificial joint material, an artificial tooth material or an artificial dental root (implant) material. Further, the sintered body of the titanium compound of the present invention can be processed to form an artificial bone, an artificial joint, an artificial tooth or an artificial dental root. Further, an artificial bone, an artificial joint, an artificial tooth or an artificial dental root can be obtained by sintering the sintered body of the titanium compound of the present invention into the desired shape of an artificial bone, an artificial joint, an artificial tooth or an artificial dental root.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Ceramic Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • Materials Engineering (AREA)
  • Structural Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Environmental & Geological Engineering (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Geology (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Compositions Of Oxide Ceramics (AREA)
US10/581,741 2003-12-18 2004-12-10 Sintered body of titanium compound Abandoned US20070112436A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/240,482 US7803194B2 (en) 2003-12-18 2008-09-29 Sintered body of titanium compound

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2003421387 2003-12-18
JP2003-421387 2003-12-18
JP2004208462 2004-07-15
JP2004-208462 2004-07-15
PCT/JP2004/018851 WO2005058754A1 (ja) 2003-12-18 2004-12-10 チタン化合物の焼結体

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2004/018851 A-371-Of-International WO2005058754A1 (ja) 2003-12-18 2004-12-10 チタン化合物の焼結体

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/240,482 Division US7803194B2 (en) 2003-12-18 2008-09-29 Sintered body of titanium compound

Publications (1)

Publication Number Publication Date
US20070112436A1 true US20070112436A1 (en) 2007-05-17

Family

ID=34703295

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/581,741 Abandoned US20070112436A1 (en) 2003-12-18 2004-12-10 Sintered body of titanium compound
US12/240,482 Expired - Fee Related US7803194B2 (en) 2003-12-18 2008-09-29 Sintered body of titanium compound

Family Applications After (1)

Application Number Title Priority Date Filing Date
US12/240,482 Expired - Fee Related US7803194B2 (en) 2003-12-18 2008-09-29 Sintered body of titanium compound

Country Status (7)

Country Link
US (2) US20070112436A1 (de)
EP (1) EP1717199B1 (de)
JP (1) JP5111761B2 (de)
KR (1) KR101132991B1 (de)
AU (1) AU2004299390B2 (de)
CA (1) CA2549866C (de)
WO (1) WO2005058754A1 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110189100A1 (en) * 2007-10-22 2011-08-04 Xavier Bourges Bone substitute containing a contrast agent, method for preparing same and uses thereof
CN115651634A (zh) * 2022-10-24 2023-01-31 大连工业大学 一种高热稳定性钙钛矿量子点/羟基磷灰石复合发光材料及其制备方法和应用

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8187660B2 (en) * 2006-01-05 2012-05-29 Howmedica Osteonics Corp. Method for fabricating a medical implant component and such component
JP2007290263A (ja) * 2006-04-26 2007-11-08 Imuno Science Kk チタン化合物の成型方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030003160A1 (en) * 1995-09-01 2003-01-02 Pugh Sydney M. Synthetic biomaterial compound of calcium phosphate phases particularly adapted for supporting bone cell activity
US6585992B2 (en) * 1995-09-01 2003-07-01 Millenium Biologix, Inc. Synthetic biomaterial compound of calcium phosphate phases particularly adapted for supporting bone cell activity
US6843943B1 (en) * 1998-10-02 2005-01-18 Doxa Aktiebolag Method of producing bioactive composite materials

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639132A (en) * 1970-04-13 1972-02-01 Bell Telephone Labor Inc Titanium dioxide ceramic composition and hot-pressing method for producing same
US3948813A (en) * 1974-12-02 1976-04-06 The United States Of America As Represented By The United States Energy Research And Development Administration Oxygen sensitive, refractory oxide composition
JPS61219753A (ja) * 1985-03-22 1986-09-30 山井　巌 低熱膨張性リン酸ジルコニルセラミツクスの製造法
JPH0616800B2 (ja) 1986-12-05 1994-03-09 春幸 川原 メッシュ構造の骨内インプラント部材
JPS6418973A (en) * 1987-07-10 1989-01-23 Agency Ind Science Techn Bioceramic material
JPS6418973U (de) 1987-07-24 1989-01-31
JPH01111763A (ja) * 1987-10-27 1989-04-28 Jgc Corp リン酸カルシウム系化合物焼結体およびその製造方法
JP2997809B2 (ja) 1989-12-18 2000-01-11 京セラ株式会社 生体インプラント部材
JPH04321556A (ja) * 1991-04-22 1992-11-11 Denki Kagaku Kogyo Kk セラミックス材料及びその製造方法
JPH05306108A (ja) * 1992-05-01 1993-11-19 Olympus Optical Co Ltd β−リン酸三カルシウム−チタン酸カルシウム複合体の製造方法
US5731251A (en) * 1993-07-12 1998-03-24 Nihon Cement Co., Ltd. Oxide ceramic sintered bodies
JP3803132B2 (ja) * 1996-01-31 2006-08-02 出光興産株式会社 ターゲットおよびその製造方法
JP3898309B2 (ja) * 1997-10-24 2007-03-28 株式会社アドバンス リン酸カルシウム系複合材の製造方法
JP3678606B2 (ja) * 1999-05-21 2005-08-03 富士通株式会社 金属修飾アパタイト及びその製造方法
JP4176282B2 (ja) 2000-04-21 2008-11-05 三菱重工業株式会社 メソポーラス無機多孔質材の製造方法
JP4061061B2 (ja) * 2001-12-12 2008-03-12 富士通株式会社 光触媒機能を有する金属修飾アパタイト膜の形成方法および金属修飾アパタイト被膜材

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030003160A1 (en) * 1995-09-01 2003-01-02 Pugh Sydney M. Synthetic biomaterial compound of calcium phosphate phases particularly adapted for supporting bone cell activity
US6585992B2 (en) * 1995-09-01 2003-07-01 Millenium Biologix, Inc. Synthetic biomaterial compound of calcium phosphate phases particularly adapted for supporting bone cell activity
US6846493B2 (en) * 1995-09-01 2005-01-25 Millenium Biologix Inc. Synthetic biomaterial compound of calcium phosphate phases particularly adapted for supporting bone cell activity
US6843943B1 (en) * 1998-10-02 2005-01-18 Doxa Aktiebolag Method of producing bioactive composite materials

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110189100A1 (en) * 2007-10-22 2011-08-04 Xavier Bourges Bone substitute containing a contrast agent, method for preparing same and uses thereof
CN115651634A (zh) * 2022-10-24 2023-01-31 大连工业大学 一种高热稳定性钙钛矿量子点/羟基磷灰石复合发光材料及其制备方法和应用

Also Published As

Publication number Publication date
KR20060127036A (ko) 2006-12-11
KR101132991B1 (ko) 2012-06-21
CA2549866A1 (en) 2005-06-30
AU2004299390A1 (en) 2005-06-30
JP5111761B2 (ja) 2013-01-09
US20090098038A1 (en) 2009-04-16
WO2005058754A1 (ja) 2005-06-30
EP1717199A1 (de) 2006-11-02
EP1717199A4 (de) 2007-09-12
CA2549866C (en) 2014-07-29
AU2004299390B2 (en) 2011-01-20
EP1717199B1 (de) 2016-11-16
US7803194B2 (en) 2010-09-28
JPWO2005058754A1 (ja) 2007-07-12

Similar Documents

Publication Publication Date Title
Famery et al. Preparation of α-and β-tricalcium phosphate ceramics, with and without magnesium addition
EP2381970B1 (de) Silikat-substituiertes hydroxylapatit
EP0298501B1 (de) Zusammensetzung zur Herstellung eines härtbaren kalziumphosphatartigen Materials und Verfahren zur Produktion eines derartigen Materials
US7803194B2 (en) Sintered body of titanium compound
Kutbay et al. Effect of calcium fluoride on mechanical behavior and sinterability of nano-hydroxyapatite and titania composites
EP2403543B1 (de) Galliumdotierte phosphorcalciumhaltige verbindungen
US8962037B2 (en) Dicalcium phosphate ceramics, dicalcium phosphate/hydroxyapatite biphasic ceramics and method of manufacturing the same
JPH078550A (ja) 医療用リン酸カルシウム
EP1298103B1 (de) Kalziumphosphat zement
CN100534897C (zh) 钛化合物的烧结体
JP3668530B2 (ja) リン酸四カルシウムの製造方法
Chou Yong et al. Influence of magnesium doping in hydroxyapatite ceramics
JPS62266065A (ja) 燐酸カルシウム含有の生体適合性層状物質およびその製造方法
CN100366301C (zh) 表面为β型磷酸三钙的珊瑚羟基磷灰石人造骨及制备方法
JP3262233B2 (ja) リン酸カルシウムの製造方法
KR100875197B1 (ko) 치아를 이용한 인산칼슘계 생체 세라믹스 및 그 제조방법.
Koç et al. Fabrication and characterization of nano-TCP doped with various ions for bone implant applications
Korzeniewski et al. Synthesis and structural characterization of niobium-doped hydroxyapatite ceramics
Ghaemi et al. The effect of Sr and Mg substitutions on structure, mechanical properties and solubility of fluorapatite ceramics for biomedical applications
JP2696345B2 (ja) リン酸カルシウム系セラミックス焼結体
Ramesh et al. Effect of forsterite addition on the densification and properties of hydroxyapatite bioceramic
GÜNGÖR KOÇ et al. Fabrication and Characterization of Nano-TCP Doped with Various Ions for Bone Implant Applications.
KR101997974B1 (ko) 하이드록시아파타이트 소결체 및 이의 제조방법
JPS63294863A (ja) 骨欠損部及び骨空隙部充填材
KR20020096521A (ko) 고강도 생체활성 세라믹복합체 및 그 제조방법

Legal Events

Date Code Title Description
AS Assignment

Owner name: IMMUNO-SCIENCE CO., INC.,JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:FUJITA, TATSUSHI;TAMURA, KENICHI;MORISAKI, YURIKO;SIGNING DATES FROM 20060516 TO 20060522;REEL/FRAME:017962/0632

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION